Insider Trading Activity FibroGen Inc (NASDAQ:FGEN) – CFO Sold 5,932 shares of Stock

ME Staff
-
0

Insider Trading Activity For FibroGen Inc (NASDAQ:FGEN)

Pat Cotroneo , CFO of FibroGen Inc (NASDAQ:FGEN) reportedly Sold 5,932 shares of the company’s stock at an average price of 54.61 for a total transaction amount of $323,946.52 SEC Form

Insider Trading History For FibroGen Inc (NASDAQ:FGEN)

  • On 6/25/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $23.57 per share and the total transaction amounting to $636,390.00.
  • On 7/6/2015 K Peony Yu, VP, sold 5,381 with an average share price of $22.69 per share and the total transaction amounting to $122,094.89.
  • On 7/9/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $22.11 per share and the total transaction amounting to $596,970.00.
  • On 7/20/2015 Pat Cotroneo, CFO, sold 7,881 with an average share price of $23.47 per share and the total transaction amounting to $184,967.07.
  • On 7/20/2015 Frank H Md Valone, Insider, sold 1,000 with an average share price of $23.70 per share and the total transaction amounting to $23,700.00.
  • On 7/23/2015 Thomas B Neff, CEO, sold 27,000 with an average share price of $24.71 per share and the total transaction amounting to $667,170.00.
  • On 9/1/2015 Frank H. Md Valone, insider, sold 10,000 with an average share price of $23.58 per share and the total transaction amounting to $235,800.00.

    • Analyst Ratings History For FibroGen Inc (NASDAQ:FGEN)

    • On 8/9/2016 Credit Suisse Group Reiterated Rating Buy with a price target of $37.00
    • On 1/18/2017 Royal Bank of Canada Reiterated Rating Buy
    • On 7/21/2017 Goldman Sachs Group Downgraded rating Buy to Neutral with a price target of $31.00
    • On 8/8/2017 Citigroup Boost Price Target of rating Top Pick with a price target of $48.00 to $65.00
    • On 8/9/2017 William Blair Reiterated Rating Outperform
    • On 9/12/2017 Jefferies Group Reiterated Rating Buy with a price target of $75.00
    • On 9/14/2017 Stifel Nicolaus Reiterated Rating Buy with a price target of $80.00

    Recent Trading Activity for FibroGen Inc (NASDAQ:FGEN)
    Shares of FibroGen Inc closed the previous trading session at with 53.400001525878906 shares trading hands.